CANF logo

CANF Retained Earnings

Latest reported-$180.79M
CANF Quarterly Retained Earnings (-$60.33M → -$180.79M)
High-resolution chart · PNG

CANF retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-180,790,000
-180,790,000
-176,189,000
-176,189,000
-171,237,000
-171,237,000
-166,361,000
-166,361,000
-162,438,000
-162,438,000
-158,481,000
-156,829,000
-155,067,000
-153,397,000
-150,847,000
-147,828,000
-145,299,000
-143,108,000
-140,674,000
-133,966,000
-130,566,000
-127,347,000
-125,469,000
-121,836,000
-119,261,000
-115,368,000
-110,210,000
-108,464,000
-105,516,000
-102,455,000
-100,623,000
-97,194,000
-97,017,000
-94,646,000
-105,657,153
-103,039,635
-103,731,091
-97,867,149
-90,977,227
-91,136,941
-86,635,684
-86,930,312
-82,711,097
-82,476,738
-82,558,496
-77,211,325
-78,108,749
-80,519,868
-85,180,481
-81,792,065
-80,514,286
-75,496,568
-72,500,302
-70,834,018
-67,281,327
-62,533,067
-61,337,599
-63,343,069
-60,847,084
-60,325,361
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.